메뉴 건너뛰기




Volumn 20, Issue 1 SUPPL., 2000, Pages 13-17

Posttransplantation: Emerging and future therapies

Author keywords

Famciclovir; Ganciclovir; Lamivudine; Therapy

Indexed keywords

ANTIVIRUS AGENT; FAMCICLOVIR; GANCICLOVIR; HEPATITIS B ANTIBODY; HUMAN IMMUNOGLOBULIN; LAMIVUDINE; NUCLEOSIDE ANALOG; VIRUS DNA;

EID: 0033918262     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (8)

References (37)
  • 1
    • 0026084824 scopus 로고
    • Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis
    • Davies SE, Portmann BC, O'Grady JG, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991;13:150-157
    • (1991) Hepatology , vol.13 , pp. 150-157
    • Davies, S.E.1    Portmann, B.C.2    O'Grady, J.G.3
  • 2
    • 0025777404 scopus 로고
    • Orthotopic liver transplantation for patients with hepatitis B virus-related disease
    • Todo S, DeMetris AJ, Van Thiel D, et al. Orthotopic liver transplantation for patients with hepatitis B virus-related disease. Hepatology 1991;13:619-626
    • (1991) Hepatology , vol.13 , pp. 619-626
    • Todo, S.1    DeMetris, A.J.2    Van Thiel, D.3
  • 3
    • 0029898537 scopus 로고    scopus 로고
    • Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro
    • Nakazono K, Ito Y, Wu CH, Wu GY. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro. Hepatology 1996;23:1297-1303
    • (1996) Hepatology , vol.23 , pp. 1297-1303
    • Nakazono, K.1    Ito, Y.2    Wu, C.H.3    Wu, G.Y.4
  • 4
    • 0030625870 scopus 로고    scopus 로고
    • Hepatitis B virus and liver transplantation: Concepts in antiviral prophylaxis
    • Grellier L, Dusheiko GM. Hepatitis B virus and liver transplantation: Concepts in antiviral prophylaxis. J Viral Hepatol 1997;4(Suppl 1):111-116
    • (1997) J Viral Hepatol , vol.4 , Issue.SUPPL. 1 , pp. 111-116
    • Grellier, L.1    Dusheiko, G.M.2
  • 5
    • 0029962626 scopus 로고    scopus 로고
    • Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin
    • Terrault NA, Zhou S, Combs C, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin Hepatology 1996;24:1327-1333
    • (1996) Hepatology , vol.24 , pp. 1327-1333
    • Terrault, N.A.1    Zhou, S.2    Combs, C.3
  • 6
    • 0031410045 scopus 로고    scopus 로고
    • Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant
    • Tchervenkov JI, Tector AJ, Barkun JS, et al. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Ann Surg 1997;226:356-365
    • (1997) Ann Surg , vol.226 , pp. 356-365
    • Tchervenkov, J.I.1    Tector, A.J.2    Barkun, J.S.3
  • 7
    • 0031034330 scopus 로고    scopus 로고
    • Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation
    • Burbach GJ, Bienzel U, Neuhaus R, et al. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation. Transplantation 1997;63:478-480
    • (1997) Transplantation , vol.63 , pp. 478-480
    • Burbach, G.J.1    Bienzel, U.2    Neuhaus, R.3
  • 8
    • 0029879163 scopus 로고    scopus 로고
    • Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization
    • McGory RW, Ishitani MB, Oliveira WM, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996;61:1358-1364
    • (1996) Transplantation , vol.61 , pp. 1358-1364
    • McGory, R.W.1    Ishitani, M.B.2    Oliveira, W.M.3
  • 9
    • 0029856065 scopus 로고    scopus 로고
    • Mercury poisoning associated with high-dose hepatitis B immune globulin administered alter liver transplantation for chronic hepatitis B
    • Lowell JA, Burgess S, Shenoy S, et al. Mercury poisoning associated with high-dose hepatitis B immune globulin administered alter liver transplantation for chronic hepatitis B. Liver Transplant Surg 1996;2:475-478
    • (1996) Liver Transplant Surg , vol.2 , pp. 475-478
    • Lowell, J.A.1    Burgess, S.2    Shenoy, S.3
  • 10
    • 0343406745 scopus 로고    scopus 로고
    • Hepatitis B virus mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
    • Ghary MG, Ayola B, Villamil FG, et al. Hepatitis B virus mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998;27: 213-222
    • (1998) Hepatology , vol.27 , pp. 213-222
    • Ghary, M.G.1    Ayola, B.2    Villamil, F.G.3
  • 11
    • 0031983151 scopus 로고    scopus 로고
    • Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation
    • Protzer-Knolle U, Naumann U, Bartenschlager R, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998;27:254-263
    • (1998) Hepatology , vol.27 , pp. 254-263
    • Protzer-Knolle, U.1    Naumann, U.2    Bartenschlager, R.3
  • 12
    • 1842291578 scopus 로고    scopus 로고
    • The treatment of chronic viral hepatitis
    • Hoofnagle JH, Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-356
    • (1997) N Engl J Med , vol.336 , pp. 347-356
    • Hoofnagle, J.H.1    Bisceglie, A.M.2
  • 13
    • 0029932608 scopus 로고    scopus 로고
    • Interferon alfa for recurrent hepatitis B infection after liver transplantation
    • Terrault NA, Holland CC, Ferrell L, et al. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transplant Surg 1996;2:132-138
    • (1996) Liver Transplant Surg , vol.2 , pp. 132-138
    • Terrault, N.A.1    Holland, C.C.2    Ferrell, L.3
  • 14
    • 0028968065 scopus 로고
    • Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression
    • Gish RG, Keefe EB, Lim J, et al. Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression. Hepatology 1995;22:257-262
    • (1995) Hepatology , vol.22 , pp. 257-262
    • Gish, R.G.1    Keefe, E.B.2    Lim, J.3
  • 15
    • 0025787396 scopus 로고
    • Liver transplantation in HBs antigen (HbsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization
    • Muller R, Gubernais G, Farle M, et al. Liver transplantation in HBs antigen (HbsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. Hepatology 1991;13:90-96
    • (1991) Hepatology , vol.13 , pp. 90-96
    • Muller, R.1    Gubernais, G.2    Farle, M.3
  • 16
    • 0030448498 scopus 로고    scopus 로고
    • Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation
    • Nymann T, Shokouh-Amiri MH, Vera SR, et al. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation. Clin Transplant 1996;10:663-667
    • (1996) Clin Transplant , vol.10 , pp. 663-667
    • Nymann, T.1    Shokouh-Amiri, M.H.2    Vera, S.R.3
  • 17
    • 16044367618 scopus 로고    scopus 로고
    • Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
    • Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996;348:1212-1215
    • (1996) Lancet , vol.348 , pp. 1212-1215
    • Grellier, L.1    Mutimer, D.2    Ahmed, M.3
  • 18
    • 0000209664 scopus 로고    scopus 로고
    • Lamivudine for suppression and/or prevention of hepatitis B when given pre/post liver transplantation (OLT)
    • Perrillo R, Rakela J, Martin P, et al. Lamivudine for suppression and/or prevention of hepatitis B when given pre/post liver transplantation (OLT) [abstract]. Hepatology 1997;26:260a
    • (1997) Hepatology , vol.26
    • Perrillo, R.1    Rakela, J.2    Martin, P.3
  • 19
    • 0000252517 scopus 로고    scopus 로고
    • Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
    • Markowitz JS, Martin P, Conrad AJ. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin [abstract]. Hepatology 1997;26:152a
    • (1997) Hepatology , vol.26
    • Markowitz, J.S.1    Martin, P.2    Conrad, A.J.3
  • 20
    • 0029683119 scopus 로고    scopus 로고
    • Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study
    • Kruger M, Tillman HL, Trautwein C, et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study. Liver Transplant Surg 1996;2:253-262
    • (1996) Liver Transplant Surg , vol.2 , pp. 253-262
    • Kruger, M.1    Tillman, H.L.2    Trautwein, C.3
  • 21
    • 0000571381 scopus 로고    scopus 로고
    • Long term lamivudine therapy of patients with recurrent hepatitis B post liver transplantation
    • Perrillo R, Rakela J, Martin P, et al. Long term lamivudine therapy of patients with recurrent hepatitis B post liver transplantation [abstract]. Hepatology 1997;26:177a
    • (1997) Hepatology , vol.26
    • Perrillo, R.1    Rakela, J.2    Martin, P.3
  • 22
    • 0030061482 scopus 로고    scopus 로고
    • Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients
    • Gish RG, Lau JYN, Brooks L, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996;23:1-7
    • (1996) Hepatology , vol.23 , pp. 1-7
    • Gish, R.G.1    Lau, J.Y.N.2    Brooks, L.3
  • 23
    • 0000209665 scopus 로고    scopus 로고
    • Management and outcome of lamivudine (LAM) resistant hepatitis B virus (HBV) infection after liver transplantation
    • Shields PL, Ling R, Harrison T, et al. Management and outcome of lamivudine (LAM) resistant hepatitis B virus (HBV) infection after liver transplantation [abstract]. Hepatology 1997;26:260a
    • (1997) Hepatology , vol.26
    • Shields, P.L.1    Ling, R.2    Harrison, T.3
  • 24
    • 0028236954 scopus 로고
    • Prostaglandin E plus famciclovir-a now concept for the treatment of severe hepatitis B after liver transplantation
    • Boker KH, Ringe B, Kruger M, et al. Prostaglandin E plus famciclovir-a now concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994;57:1706-1708
    • (1994) Transplantation , vol.57 , pp. 1706-1708
    • Boker, K.H.1    Ringe, B.2    Kruger, M.3
  • 25
    • 0001228985 scopus 로고    scopus 로고
    • Safety and efficacy of famciclovir for the treatment of recurrent hepatitis B in liver transplant recipients
    • Neuhaus P, Manns MP, Atkinson G. Safety and efficacy of famciclovir for the treatment of recurrent hepatitis B in liver transplant recipients [abstract]. Hepatology 1997;26:260a
    • (1997) Hepatology , vol.26
    • Neuhaus, P.1    Manns, M.P.2    Atkinson, G.3
  • 26
    • 0000486639 scopus 로고    scopus 로고
    • Prolonged therapy of recurrent hepatitis B infection after liver transplantation with nucleoside analogues
    • Jaeckel E, Tillmann HL, Kruger M, et al. Prolonged therapy of recurrent hepatitis B infection after liver transplantation with nucleoside analogues [abstract]. J Hepatol 1998;28(suppl):115a
    • (1998) J Hepatol , vol.28 , Issue.SUPPL.
    • Jaeckel, E.1    Tillmann, H.L.2    Kruger, M.3
  • 27
    • 0019813866 scopus 로고
    • Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
    • Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435
    • (1981) Hepatology , vol.1 , pp. 431-435
    • Knodell, R.G.1    Ishak, K.G.2    Black, W.C.3
  • 28
    • 0001242734 scopus 로고    scopus 로고
    • Hepatitis B virus polymerase mutations during famciclovir therapy in patients following liver transplantation
    • Aye TT, Bartholomeusz AI, Shaw T, et al. Hepatitis B virus polymerase mutations during famciclovir therapy in patients following liver transplantation [abstract]. Hepatitis 1996;24:285a
    • (1996) Hepatitis , vol.24
    • Aye, T.T.1    Bartholomeusz, A.I.2    Shaw, T.3
  • 29
    • 0030905343 scopus 로고    scopus 로고
    • Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation
    • Aye TT, Bartholomeusz AI, Shaw T, et al. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J Hepatol 1997;26:1148-1153
    • (1997) J Hepatol , vol.26 , pp. 1148-1153
    • Aye, T.T.1    Bartholomeusz, A.I.2    Shaw, T.3
  • 30
    • 0029817898 scopus 로고    scopus 로고
    • Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
    • Tipples GA, Ma MM, Fischer KP, et al. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996;24:714-717
    • (1996) Hepatology , vol.24 , pp. 714-717
    • Tipples, G.A.1    Ma, M.M.2    Fischer, K.P.3
  • 31
    • 0009218685 scopus 로고    scopus 로고
    • Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
    • Bartholomew MM, Jansen RW, Jeffers LH, et al. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1996;348:1212-1215
    • (1996) Lancet , vol.348 , pp. 1212-1215
    • Bartholomew, M.M.1    Jansen, R.W.2    Jeffers, L.H.3
  • 32
    • 0001674626 scopus 로고    scopus 로고
    • Famciclovir treatment in lamivudine resistant chronic hepatitis B patients
    • Wolters LMM, Honkoop P, de Man RA, et al. Famciclovir treatment in lamivudine resistant chronic hepatitis B patients [abstract]. J Hepatol 1998;28(Suppl 1):113a
    • (1998) J Hepatol , vol.28 , Issue.SUPPL. 1
    • Wolters, L.M.M.1    Honkoop, P.2    De Man, R.A.3
  • 33
    • 0008384291 scopus 로고    scopus 로고
    • Response and mutations in patients sequentially treated with lamivudine and famciclovir for recurrent hepatitis B after liver transplantation
    • Tillmann HL, Trautwein C, Bock T, et al. Response and mutations in patients sequentially treated with lamivudine and famciclovir for recurrent hepatitis B after liver transplantation [abstract]. Hepatology 1997;26:429a
    • (1997) Hepatology , vol.26
    • Tillmann, H.L.1    Trautwein, C.2    Bock, T.3
  • 34
    • 0031938029 scopus 로고    scopus 로고
    • Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
    • Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1997;27:628-633
    • (1997) Hepatology , vol.27 , pp. 628-633
    • Melegari, M.1    Scaglioni, P.P.2    Wands, J.R.3
  • 35
    • 0030926706 scopus 로고    scopus 로고
    • Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro
    • Colledge D, Locarnini S, Shaw T. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology 1997;26:216-225
    • (1997) Hepatology , vol.26 , pp. 216-225
    • Colledge, D.1    Locarnini, S.2    Shaw, T.3
  • 37
    • 0000076031 scopus 로고    scopus 로고
    • Lack of cross resistance to PMEA for human hepatitis B DNA polymerases which express lamivudine resistance codons
    • Xioing X, Flores C, Gibbs C, et al. Lack of cross resistance to PMEA for human hepatitis B DNA polymerases which express lamivudine resistance codons [abstract]. Hepalology 1997; 26:431a
    • (1997) Hepalology , vol.26
    • Xioing, X.1    Flores, C.2    Gibbs, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.